All pharmaceutical manufacturers intending to market or manufacture their products in the EU must comply with good manufacturing practice (GMP), regardless of where in the world they are based. GMP defines the minimum standards that a pharmaceutical manufacturer must meet in its production processes.
By following GMP, manufacturers can systematically prevent contamination, errors and inconsistencies, which is crucial for patient safety. Compliance with GMP is necessary to obtain authorization to manufacture and distribute Pharma. Each country's medicines regulatory authority issues these licenses and conducts regular inspections to ensure that manufacturers' quality systems are functioning and that regulations and guidelines are being followed.
